• AI-Based Urine Stem Cell Mitochondrial Profiling for Alzheim

  2026-07-21

  This study pioneers a deep learning approach to non-invasively profile mitochondrial morphology in urine-derived stem cells, distinguishing Alzheimer’s and mild cognitive impairment from healthy controls. The method enables dynamic, patient-specific assessment of mitochondrial dysfunction, with significant potential for accessible early-stage biomarker development.

• Moxifloxacin in Translational Research: Mechanism and Strate

  2026-07-21

  This article delivers a thought-leadership perspective on Moxifloxacin, a fluoroquinolone antibiotic, as a powerful research tool in translational science. By weaving together mechanistic insights, experimental validation, and strategic workflow guidance, we explore how high-purity Moxifloxacin from APExBIO can accelerate discovery in fields ranging from antibiotic toxicity to metabolic response. With detailed discussion of DNA gyrase inhibition, cytotoxicity, and translational workflow design, this piece elevates the conversation beyond traditional product pages and provides actionable intelligence for forward-thinking researchers.

• METTL16-SENP3-LTF Axis Mediates Ferroptosis Resistance in HC

  2026-07-20

  Wang et al. reveal that the METTL16-SENP3-LTF signaling axis confers resistance to ferroptosis and drives hepatocellular carcinoma (HCC) progression by modulating RNA methylation and iron metabolism. These findings identify a novel regulatory mechanism and highlight potential therapeutic targets for overcoming ferroptosis resistance in HCC.

• Practical Use of HyperPFU™ High-Fidelity DNA Polymerase (K10

  2026-07-20

  HyperPFU™ high-fidelity DNA polymerase is designed for accurate and robust PCR amplification of long, GC-rich, or otherwise difficult DNA templates, where standard polymerases often fail. It is optimal when blunt-ended, high-fidelity PCR products are needed for cloning or high-throughput sequencing. It should not be used for protocols requiring 3'-A overhangs or sticky ends.

• CCCP and Mitochondrial Morphodynamics: Beyond Proton Gradien

  2026-07-19

  Explore how CCCP (carbonyl cyanide m-chlorophenyl hydrazine) enables frontier research into mitochondrial morphology and systemic dysfunction. This article uncovers new assay strategies and practical insights not found in standard CCCP guides.

• Aurora A Targeting with MLN8237: Translational Leverage in O

  2026-07-18

  This article examines the mechanistic and translational value of MLN8237 (Alisertib) as a selective Aurora A kinase inhibitor. Drawing on recent findings in retinoblastoma and the broader oncology landscape, it provides actionable guidance for researchers aiming to translate molecular insights into impactful preclinical and clinical strategies. This perspective uniquely bridges rigorous mechanistic detail with strategic workflow recommendations, surpassing conventional product overviews.

• Y-27632: Selective ROCK Inhibitor for Cytoskeletal Modulatio

  2026-07-17

  Y-27632 is a potent, selective ROCK inhibitor widely used for dissecting cytoskeletal dynamics in cell biology. It demonstrates high specificity for ROCK1/2, disrupts stress fibers, and supports advanced research workflows. Peer-reviewed evidence and APExBIO's product data establish its reliability and practical best-use scenarios.

• miR-24-3p Regulates Cardiac Injury via Sp1/PI3K in Doxorubic

  2026-07-17

  This study demonstrates that miR-24-3p exacerbates cardiac dysfunction in doxorubicin-induced heart failure through direct suppression of the Sp1/PI3K signaling pathway. Silencing miR-24-3p confers cardioprotective effects, revealing a newly defined regulatory axis and potential therapeutic target for heart failure models.

• Probenecid in Research: Protocols, Neuroprotection & MDR Rev

  2026-07-16

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) is uniquely positioned to empower multidrug resistance (MDR) reversal in oncology and neuroprotection in cerebral ischemia/reperfusion models. This article guides researchers through optimized workflows, advanced troubleshooting, and strategic applications, leveraging APExBIO’s validated product for robust, reproducible results.

• Moxifloxacin: Applied Protocols for Antibiotic Toxicity Rese

  2026-07-16

  Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, enables precise modeling of antibiotic toxicity, cellular proliferation, and metabolic shifts in both bacterial and mammalian systems. This guide details actionable workflows, protocol optimizations, and troubleshooting tips that empower high-impact research—anchored by mechanistic innovation and APExBIO’s rigorous standards.

• Epigenetic Activation of PDK1 Drives TKI Resistance in Cance

  2026-07-15

  The reference study uncovers a novel epigenetic pathway involving KDM3A and METTL16 that elevates PDK1 expression, promoting resistance to EGFR tyrosine kinase inhibitors (TKIs) and facilitating cancer progression. These findings have important implications for developing targeted therapies and robust biomarkers to overcome TKI resistance.

• CCCP (carbonyl cyanide m-chlorophenyl hydrazine): Mitochondr

  2026-07-15

  Explore how CCCP (carbonyl cyanide m-chlorophenyl hydrazine) enables advanced modeling of mitochondrial dysfunction in human-derived cell systems. This article provides a uniquely detailed analysis of CCCP’s mechanistic value, practical assay insights, and the latest deep learning-driven biomarker discovery for neurodegenerative disease research.

• TaqI Restriction Endonuclease: Rapid DNA Digestion Protocols

  2026-07-14

  TaqI Restriction Endonuclease (SKU K3053) addresses the need for rapid, efficient digestion of plasmid, PCR, or genomic DNA in molecular biology workflows. It is intended for research use only and should not be used in diagnostic or clinical applications.

• Zosuquidar (LY335979): Empowering Multidrug Resistance Rever

  2026-07-14

  Zosuquidar (LY335979) 3HCl is reshaping cancer research by enabling precise, robust inhibition of the P-glycoprotein efflux pump—a pivotal mechanism of multidrug resistance. From acute myeloid leukemia to solid tumors, discover how this compound streamlines workflows, enhances chemotherapy efficacy, and integrates with advanced transporter biology insights.

• Dextrose (D-glucose) for Precision Glucose Metabolism Resear

  2026-07-13

  Dextrose (D-glucose) from APExBIO accelerates metabolic pathway and immunometabolism research with unmatched purity, solubility, and assay compatibility. Discover how to optimize workflows and troubleshoot challenges in tumor microenvironment studies using this gold-standard substrate.

11494 records 1/767 page Next 12345 下5页 Last page